1-20 of 40548
Sort by
Journal Article
Clinical Chemistry, hvaa188, https://doi.org/10.1093/clinchem/hvaa188
Published: 25 August 2020
Journal Article
Clinical Chemistry, hvaa165, https://doi.org/10.1093/clinchem/hvaa165
Published: 23 August 2020
Journal Article
Clinical Chemistry, hvaa161, https://doi.org/10.1093/clinchem/hvaa161
Published: 23 August 2020
Journal Article
Clinical Chemistry, hvaa200, https://doi.org/10.1093/clinchem/hvaa200
Published: 21 August 2020
Journal Article
Clinical Chemistry, hvaa159, https://doi.org/10.1093/clinchem/hvaa159
Published: 20 August 2020
Image
Published: 20 August 2020
Fig. 3. Immune repertoire sequencing of γδ T cells. a) Number of productive TRD molecules for each assay, versus starting amount of γδ T-cell DNA. The linear correlation of each assay is shown, n = 3. b) Correction of molecule quantification using UMIs. Relative frequencies of clonotypes using raw sequencin
Image
Published: 20 August 2020
Fig. 5. Comparison of immune repertoire sequencing of enriched and non-enriched γδ T cells from PBMCs. Peripheral blood mononuclear cells (PBMCs) from one individual were split in half: one sample was enriched for γδ T cells, while the other was analyzed directly without cell enrichment. a) Each point is a
Image
Published: 20 August 2020
Fig. 1. Illustration of δ T-cell receptor repertoire sequencing. a) Schematic overview of the unrearranged TRD locus, arrows show transcription direction. b) SiMSen-Seq consists of two rounds of PCR. In the first barcoding PCR, target primers bind to the V and J genes, generating specific PCR products with
Image
Published: 20 August 2020
Fig. 2. Performance of 32-plex assay targeting TRD sequences. a) Dynamic range of 32-plex assay. Quantitative PCR on barcoded synthetic gBlock molecules, ranging from 2 · 10 ^ 7 to 20 molecules per standard with 10-fold dilution steps. Cycle of quantification value (Cq-value) is shown, n = 3
Image
Published: 20 August 2020
Fig. 4. The immune repertoire of TRD in healthy individuals. a) The number of productive TRD molecules detected by sequencing compared with the amount of γδ T-cell DNA used, assuming 139 productive molecules per nanogram DNA. b) Treemapping of all clonotypes across 10 healthy individuals. Each square repres
Journal Article
Clinical Chemistry, hvaa171, https://doi.org/10.1093/clinchem/hvaa171
Published: 18 August 2020
Journal Article
Clinical Chemistry, hvaa133, https://doi.org/10.1093/clinchem/hvaa133
Published: 16 August 2020
Image
Published: 14 August 2020
Fig. 2. Mass spectrum of peptide a) MVLYTLRAPRSPK generated by Lys-C from proBNP in an 18 O buffer; Blue peaks reflect single 18 O labeled 12 C and 13 C peaks of the peptide, whereas red peaks reflect nonlabeled signals; The abundance of the nonlabeled peptide matches the manufacturer’s claims of 16 O
Image
Published: 14 August 2020
Fig. 3. Relative distribution of nonglycosylated N-terminally truncated (NT-) proBNP forms circulating in 8 HF patients; depicted is the mean value and range of 3 replicates; missing values indicate no signal detected.
Image
Published: 14 August 2020
Fig. 6. Overview of identified peptides corresponding to in vivo a) N-terminally truncated molecular forms described in Fig. 3 and b) C-terminally truncated molecular forms, NT-proBNP or proBNP described in Fig. 4 .
Image
Published: 14 August 2020
Fig. 1. Schematic overview of identified circulating molecular forms of proBNP and NT-proBNP in HF patients and controls. Also shown is the current understanding of proBNP processing by furin (red arrow) and corin (green arrows) as well as O-glycosylation and N- and C-terminal degradation of (NT-) proBNP; b
Image
Published: 14 August 2020
Fig. 4. Relative distribution of nonglycosylated C-terminally truncated (NT-) proBNP forms, NT-proBNP and proBNP circulating in 8 HF patients; depicted is the mean value and range of three replicates.
Image
Published: 14 August 2020
Fig. 5. Relative distribution of A) nonglycosylated N-terminally truncated (NT-) proBNP forms circulating in 2 healthy subjects, and B) nonglycosylated C-terminally truncated (NT-) proBNP forms circulating in 2 healthy subjects; missing value indicates no signal detected.
Journal Article
Clinical Chemistry, hvaa130, https://doi.org/10.1093/clinchem/hvaa130
Published: 14 August 2020
Journal Article
Clinical Chemistry, hvaa128, https://doi.org/10.1093/clinchem/hvaa128
Published: 13 August 2020